Country · Healthcare markets
Kenya healthcare markets
178 reports across 5 categories, with market size and growth to 2033.
Kenya healthcare markets178 reports across 5 categories, with market size and growth to 2033.
2023–2033 CAGR · estimates
Market size in 2023 · share of the world market
Active trials (recruiting, about to start or running)
Medtronic30 reports
Johnson & Johnson27 reports
Abbott Laboratories25 reports
Pfizer Inc.24 reports
GE Healthcare23 reports
Siemens Healthineers21 reports
Novartis AG19 reports
Philips Healthcare16 reports
Bayer AG15 reports
Merck & Co., Inc.15 reports
Sanofi15 reports
IBM Watson Health13 reports
Each market name opens its Kenya report. To compare one market across every country, see market statistics.
| Market | 2023 | 2033 (projected) | CAGR | World share | Active trials |
|---|---|---|---|---|---|
| Alopecia areata | – | – | – | – | 0 |
| Alzheimers Dignostic | $2 Mn | $3 Mn | 8% | 0.1% | 0 |
| Ambulance Service | $22 Mn | $48 Mn | 8.2% | 0.1% | 6 |
| Ambulatory Surgery Center | $28 Mn | $56 Mn | 7.2% | 0.1% | 6 |
| Antimicrobial Susceptibility Testing | – | – | – | – | 1 |
| Bioinformatics | $9 Mn | $36 Mn | 15.5% | 0.1% | – |
| Biomaterial Wound Dressing | $6 Mn | $12 Mn | 7.8% | 0.1% | 0 |
| Blood Gas and Electrolyte Analyzers | $2 Mn | $4 Mn | 7.5% | 0.1% | 0 |
| Bone Cancer Diagnostic | $1 Mn | $2 Mn | 8.5% | 0.1% | 0 |
| Brain Cancer Diagnostic | $1 Mn | $4 Mn | 14.7% | 0.1% | 0 |
| Breast Cancer Diagnostic | $3 Mn | $7 Mn | 8.9% | 0.1% | – |
| Clinical Laboratory Service | – | – | – | – | – |
| Dental Care Service | – | – | – | – | – |
| Dental Imaging | $2 Mn | $6 Mn | 9% | 0.1% | – |
| Dermatology Diagnostic | $18 Mn | $58 Mn | 12.3% | 0.1% | 6 |
| Fertility Service | $15 Mn | $30 Mn | 7.2% | 0.1% | – |
| Healthcare Electronic Data Interchange (EDI) | $3 Mn | $8 Mn | 10.5% | 0.1% | 1 |
| Healthcare In Vitro Diagnostic | $59 Mn | $94 Mn | 4.9% | 0.1% | 3 |
| Hospitals and Health Systems | $3 Bn | $5.8 Bn | 6.7% | 0.1% | 87 |
| Medical Billing | $3 Mn | $10 Mn | 12.5% | 0.1% | 0 |
| Medical Tourism | $52 Mn | $181 Mn | 13.3% | 0.1% | 0 |
| Nursing Education | $7 Mn | $17 Mn | 9.2% | 0.1% | 2 |
| Patient Support Programs (PSP) | $12 Mn | $57 Mn | 16.9% | 0.1% | 8 |
| Point Of Care (PoC) Molecular Diagnostic | $13 Mn | $35 Mn | 10.4% | 0.1% | 2 |
| Market | 2023 | 2033 (projected) | CAGR | World share | Active trials |
|---|---|---|---|---|---|
| Acute Care Needleless Connectors | $0 Mn | $1 Mn | 8.6% | 0.1% | – |
| Advanced Bipolar Direct Energy Devices | $2 Mn | $6 Mn | 9.8% | 0.1% | – |
| Aesthetic Lasers and Energy Devices | $1 Mn | $4 Mn | 13.2% | 0.1% | – |
| Air Ambulance Life Support Solutions | $3 Mn | $8 Mn | 10.2% | 0.1% | – |
| Airway Management Devices | $1 Mn | $3 Mn | 6.3% | 0.1% | – |
| Anastomosis Devices | $2 Mn | $5 Mn | 7.9% | 0.1% | – |
| Anesthesia & Respiratory Devices | $20 Mn | $55 Mn | 10.6% | 0.1% | – |
| Anesthesia Monitoring Devices | $2 Mn | $7 Mn | 13.6% | 0.1% | – |
| Angiography Devices | $9 Mn | $18 Mn | 7.4% | 0.1% | – |
| Angioplasty Balloons | $3 Mn | $5 Mn | 4.9% | 0.1% | – |
| Anti-Snoring Devices | $1 Mn | $2 Mn | 9.9% | 0.1% | – |
| Apheresis Equipments | $2 Mn | $4 Mn | 7.3% | 0.1% | – |
| Arrhythmia Monitoring Devices | $4 Mn | $8 Mn | 6.6% | 0.1% | – |
| Assisted Walking Aids | $2 Mn | $3 Mn | 6.6% | 0.1% | – |
| Audiology Devices | $6 Mn | $11 Mn | 7.5% | 0.1% | – |
| Defibrillator | $12 Mn | $24 Mn | 7% | 0.1% | – |
| Dental Articulators | $0 Mn | $1 Mn | 7.5% | 0.1% | – |
| Dental Caries Detectors | $0 Mn | $1 Mn | 12.9% | 0.1% | – |
| Dental Diagnostic and Surgical Equipments | $8 Mn | $18 Mn | 8.2% | 0.1% | – |
| Dental X-Ray Equipments | $1 Mn | $3 Mn | 8.3% | 0.1% | – |
| Diabetes Care Devices | $30 Mn | $59 Mn | 7% | 0.1% | – |
| Digital Diabetes Management | – | – | – | – | – |
| Direct Energy Medical Devices | $8 Mn | $14 Mn | 6.1% | 0.1% | – |
| Disposable Surgical Devices | $6 Mn | $14 Mn | 8.4% | 0.1% | – |
| Insulin Delivery Devices | $11 Mn | $23 Mn | 7.6% | 0.1% | – |
| Insulin Patch Pumps | $1 Mn | $2 Mn | 13.1% | 0.1% | – |
| Rehabilitation Equipments | $14 Mn | $28 Mn | 7.2% | 0.1% | – |
| Market | 2023 | 2033 (projected) | CAGR | World share | Active trials |
|---|---|---|---|---|---|
| Adaptogens | $6 Mn | $14 Mn | 9.6% | 0.1% | – |
| Amino Acid | – | – | – | – | – |
| Anthelmintic Drug | – | – | – | – | – |
| Antioxidants | – | – | – | – | – |
| Antipyretics OTC | – | – | – | – | – |
| BCAA Supplement | $1 Mn | $2 Mn | 7.8% | 0.1% | – |
| Beauty Supplements | $3 Mn | $8 Mn | 10.3% | 0.1% | – |
| Biotin Supplement | $0 Mn | $1 Mn | 6.1% | 0.1% | – |
| Bone & Joint Health Supplements | $8 Mn | $17 Mn | 7.5% | 0.1% | – |
| Calcium Supplements | $2 Mn | $4 Mn | 7.1% | 0.1% | – |
| Cannabidiol (CBD) Supplements | $4 Mn | $19 Mn | 17.9% | 0.1% | – |
| Cardiovascular Health Supplements | $5 Mn | $9 Mn | 6.8% | 0.1% | – |
| Clinical Nutrition | $20 Mn | $44 Mn | 8.2% | 0.1% | – |
| Coenzyme Q10 | $0 Mn | $1 Mn | 10.1% | 0.1% | – |
| Collagen Supplements | $2 Mn | $3 Mn | 7.2% | 0.1% | – |
| Creatine | $0 Mn | $1 Mn | 7.4% | 0.1% | – |
| Dietary Supplements | $216 Mn | $436 Mn | 7.3% | 0.1% | – |
| Eye Health Supplements | $2 Mn | $4 Mn | 7.3% | 0.1% | – |
| Functional Food | $200 Mn | $423 Mn | 7.8% | 0.1% | – |
| Hair Growth Supplements | $1 Mn | $3 Mn | 8.4% | 0.1% | – |
| Herbal Supplements | $57 Mn | $132 Mn | 8.7% | 0.1% | – |
| Immune Health Supplement | – | – | – | – | – |
| Iron Supplement | $1 Mn | $3 Mn | 7.6% | 0.1% | – |
| Men's Health Supplements | $13 Mn | $27 Mn | 7.9% | 0.1% | – |
| Mood and Stress Supplements | $7 Mn | $18 Mn | 9.2% | 0.1% | – |
| Nutritional Supplements | $270 Mn | $577 Mn | 7.9% | 0.1% | – |
| Omega 3 Fatty Acid | $3 Mn | $7 Mn | 8.5% | 0.1% | – |
| Oncology Nutrition | $2 Mn | $3 Mn | 8.4% | 0.1% | – |
| Osteoporosis Supplements | $2 Mn | $5 Mn | 7.6% | 0.1% | – |
| Over The Counter (OTC) Analgesics | $15 Mn | $24 Mn | 4.5% | 0.1% | – |
| Over The Counter (OTC) Antifungal | $2 Mn | $3 Mn | 4.9% | 0.1% | – |
| Over The Counter (OTC) Consumer | $106 Mn | $195 Mn | 6.3% | 0.1% | – |
| Over The Counter (OTC) Drugs | $125 Mn | $219 Mn | 5.8% | 0.1% | – |
| Over The Counter (OTC) Gastrointestinal Drugs | $4 Mn | $6 Mn | 5% | 0.1% | – |
| Over The Counter (OTC) Medications for Cough, Cold & Flu Drugs | $10 Mn | $17 Mn | 5.2% | 0.1% | – |
| Over The Counter (OTC) Ophthalmic Drugs | $3 Mn | $4 Mn | 5.6% | 0.1% | – |
| Over The Counter (OTC) Pharmaceuticals | $125 Mn | $219 Mn | 5.8% | 0.1% | – |
| Over The Counter (OTC) Sleep Aid Products | $4 Mn | $6 Mn | 5.1% | 0.1% | – |
| Over The Counter (OTC) Vitamins and Minerals | $22 Mn | $42 Mn | 6.6% | 0.1% | – |
| Plant-Based Supplements | $9 Mn | $21 Mn | 9.1% | 0.1% | – |
| Prebiotics | $6 Mn | $19 Mn | 12.9% | 0.1% | – |
| Probiotic Supplements for Gut Health | $4 Mn | $10 Mn | 8.3% | 0.1% | – |
| Protein Supplement | $14 Mn | $32 Mn | 8.5% | 0.1% | – |
| Sports Nutrition | $36 Mn | $86 Mn | 9% | 0.1% | – |
| Vitamin B12(Cobalamin) | $0 Mn | $0 Mn | 6.6% | 0.1% | – |
| Vitamin D Supplements | – | – | – | – | – |
| Weight Management Supplement | – | – | – | – | – |
| Women's Health Supplements | $14 Mn | $30 Mn | 7.9% | 0.1% | – |
| Market | 2023 | 2033 (projected) | CAGR | World share | Active trials |
|---|---|---|---|---|---|
| Abuse Deterrent Opioids | – | – | – | – | – |
| Alexipharmic Drugs | – | – | – | – | – |
| Alopecia Drugs (Hair Loss) | – | – | – | – | – |
| Alzheimer Drugs | $3.5 Bn | $7.5 Bn | 7.9% | – | – |
| Aminoglycosides | – | – | – | – | – |
| Anemia Drugs | – | – | – | – | – |
| Anti-Aging | $62 Mn | $149 Mn | 9.2% | 0.1% | – |
| Anti-Depressants Drugs | $13 Mn | $18 Mn | 3.8% | 0.1% | – |
| Anti-Nerve Growth Factor | – | – | – | – | – |
| Anti-Venom | – | – | – | – | – |
| Anticoagulants | – | – | – | – | – |
| Antithrombotic Drugs | – | – | – | – | – |
| Artificial Skin | $2 Mn | $3 Mn | 6.9% | 0.1% | – |
| Asthma & COPD Drugs | $35 Mn | $57 Mn | 5.1% | 0.1% | – |
| Atherosclerosis Drugs | – | – | – | – | – |
| Atopic Dermatitis Drugs | $8 Mn | $27 Mn | 13.3% | 0.1% | – |
| Autologous Matrix-induced Chondrogenesis | – | – | – | – | – |
| Axial Spondyloarthritis (axSpA) | – | – | – | – | – |
| Biological Safety Testing | – | – | – | – | – |
| Biosimilar Monoclonal Antibodies | – | – | – | – | – |
| Biosimilars | $26 Mn | $261 Mn | 26% | 0.1% | – |
| Blood Plasma | – | – | – | – | – |
| Bone Marrow Aspirate Concentrates | – | – | – | – | – |
| Burn Care | – | – | – | – | – |
| Burn Ointment | – | – | – | – | – |
| Cancer Supportive Care Drugs | $17 Mn | $31 Mn | 5.8% | 0.1% | – |
| Cannabidiol (CBD) | $15 Mn | $80 Mn | 17.9% | 0.1% | – |
| Cannabis | $24 Mn | $93 Mn | 14.6% | 0.1% | – |
| Cell Based Immunotherapy | $12 Mn | $101 Mn | 24.1% | 0.1% | – |
| Contraceptives Drugs | $18 Mn | $38 Mn | 7.9% | 0.1% | – |
| Cord Blood Banking Service | $1 Mn | $3 Mn | 7.6% | 0.1% | – |
| Diabetes Management | $55 Mn | $120 Mn | 8.2% | 0.1% | – |
| Diabetic Retinopathy Drugs | $8 Mn | $15 Mn | 7.1% | 0.1% | – |
| Epilepsy Drugs | $7 Mn | $11 Mn | 4.6% | 0.1% | – |
| Gastroesophageal Reflux Disease (GERD) Drugs | $4 Mn | $5 Mn | 3.2% | 0.1% | – |
| Gastrointestinal Drugs | $38 Mn | $66 Mn | 5.7% | 0.1% | – |
| HIV Drugs | $21 Mn | $41 Mn | 6.9% | 0.1% | – |
| Oncology/Cancer Drugs | $124 Mn | $307 Mn | 9.5% | 0.1% | – |
"–" means we have no size for that market here yet. Values for 2033 are projected from the 2023 size and the CAGR.
Sources: market sizes and growth: Acuitas Health Analytics research. Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide, and one trial can count in more than one market. Health figures: WHO Global Health Observatory. People and health spending: World Bank. Public figures fetched 10 Nov 2026.